Free Trial

Insider Selling: Arteris, Inc. (NASDAQ:AIP) CFO Sells 5,968 Shares of Stock

Arteris logo with Computer and Technology background
Remove Ads

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas B. Hawkins sold 5,968 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $8.57, for a total value of $51,145.76. Following the sale, the chief financial officer now directly owns 186,123 shares of the company's stock, valued at $1,595,074.11. This represents a 3.11 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Arteris Stock Performance

AIP stock traded up $0.01 during trading hours on Friday, hitting $7.89. 206,807 shares of the stock were exchanged, compared to its average volume of 306,116. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $323.08 million, a P/E ratio of -9.07 and a beta of 1.21. The company has a 50-day simple moving average of $10.29 and a two-hundred day simple moving average of $8.82. Arteris, Inc. has a 12 month low of $5.76 and a 12 month high of $12.64.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The company had revenue of $15.49 million during the quarter, compared to the consensus estimate of $15.34 million. On average, analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Remove Ads

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. US Bancorp DE bought a new position in shares of Arteris in the third quarter worth $34,000. Quarry LP bought a new position in shares of Arteris in the fourth quarter worth $46,000. R Squared Ltd bought a new position in shares of Arteris in the fourth quarter worth $64,000. D. E. Shaw & Co. Inc. bought a new position in shares of Arteris in the fourth quarter worth $110,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of Arteris in the fourth quarter worth $117,000. Institutional investors own 64.36% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on AIP. Northland Securities increased their target price on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th. Rosenblatt Securities reissued a "buy" rating and set a $15.00 target price on shares of Arteris in a research note on Tuesday, February 18th.

Get Our Latest Analysis on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads